SLC6A3 and Parkinson disease: Though loss of dopaminergic neurons as measured for example by dopamine transporter single photon emission tomography (DAT-SPECT) is consistently found to be correlated with PD motor symptoms at advanced disease stages, data on its association to symptom severity in de novo PD is rather limited (Pirker, 2003; McGhee et al., 2013).